vs
Side-by-side financial comparison of Expeditors International (EXPD) and TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). Click either name above to swap in a different company.
TEVA PHARMACEUTICAL INDUSTRIES LTD is the larger business by last-quarter revenue ($4.0B vs $2.9B, roughly 1.4× Expeditors International). TEVA PHARMACEUTICAL INDUSTRIES LTD runs the higher net margin — 9.3% vs 7.0%, a 2.2% gap on every dollar of revenue. On growth, TEVA PHARMACEUTICAL INDUSTRIES LTD posted the faster year-over-year revenue change (100.0% vs -3.3%). Expeditors International produced more free cash flow last quarter ($270.3M vs $188.0M). Over the past eight quarters, Expeditors International's revenue compounded faster (13.8% CAGR vs -2.2%).
Expeditors International of Washington, Inc. is an American Fortune 500 service-based logistics company with headquarters in Bellevue, Washington. Expeditors generates highly optimized and customized supply chain solutions for clients with unified technology systems integrated through a global network of over 340+ locations in 100+ countries on six continents.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.
EXPD vs TEVA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.9B | $4.0B |
| Net Profit | $200.7M | $369.0M |
| Gross Margin | — | 26.1% |
| Operating Margin | 8.8% | — |
| Net Margin | 7.0% | 9.3% |
| Revenue YoY | -3.3% | 100.0% |
| Net Profit YoY | -14.9% | 67.7% |
| EPS (diluted) | $1.50 | $-0.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $4.0B | ||
| Q4 25 | $2.9B | $4.7B | ||
| Q3 25 | $2.9B | $4.5B | ||
| Q2 25 | $2.7B | $4.2B | ||
| Q1 25 | $2.7B | $3.9B | ||
| Q4 24 | $3.0B | $4.2B | ||
| Q3 24 | $3.0B | $4.3B | ||
| Q2 24 | $2.4B | $4.2B |
| Q1 26 | — | $369.0M | ||
| Q4 25 | $200.7M | $481.0M | ||
| Q3 25 | $222.3M | $433.0M | ||
| Q2 25 | $183.6M | $282.0M | ||
| Q1 25 | $203.8M | $214.0M | ||
| Q4 24 | $235.9M | $-217.0M | ||
| Q3 24 | $229.6M | $-437.0M | ||
| Q2 24 | $175.5M | $-846.0M |
| Q1 26 | — | 26.1% | ||
| Q4 25 | — | 56.4% | ||
| Q3 25 | — | 51.4% | ||
| Q2 25 | — | 50.3% | ||
| Q1 25 | — | 48.2% | ||
| Q4 24 | — | 50.2% | ||
| Q3 24 | — | 49.6% | ||
| Q2 24 | — | 48.6% |
| Q1 26 | — | — | ||
| Q4 25 | 8.8% | 6.4% | ||
| Q3 25 | 10.0% | 19.7% | ||
| Q2 25 | 9.3% | 10.9% | ||
| Q1 25 | 10.0% | 13.3% | ||
| Q4 24 | 10.2% | -0.7% | ||
| Q3 24 | 10.1% | -1.2% | ||
| Q2 24 | 9.2% | -0.1% |
| Q1 26 | — | 9.3% | ||
| Q4 25 | 7.0% | 10.2% | ||
| Q3 25 | 7.7% | 9.7% | ||
| Q2 25 | 6.9% | 6.8% | ||
| Q1 25 | 7.6% | 5.5% | ||
| Q4 24 | 8.0% | -5.1% | ||
| Q3 24 | 7.7% | -10.1% | ||
| Q2 24 | 7.2% | -20.3% |
| Q1 26 | — | $-0.66 | ||
| Q4 25 | $1.50 | $0.42 | ||
| Q3 25 | $1.64 | $0.37 | ||
| Q2 25 | $1.34 | $0.24 | ||
| Q1 25 | $1.47 | $0.18 | ||
| Q4 24 | $1.68 | $-0.19 | ||
| Q3 24 | $1.63 | $-0.39 | ||
| Q2 24 | $1.24 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3B | $3.7B |
| Total DebtLower is stronger | — | $2.6B |
| Stockholders' EquityBook value | $2.4B | $8.2B |
| Total Assets | $4.9B | $40.0B |
| Debt / EquityLower = less leverage | — | 0.32× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $3.7B | ||
| Q4 25 | $1.3B | $3.6B | ||
| Q3 25 | $1.2B | $2.2B | ||
| Q2 25 | $1.2B | $2.2B | ||
| Q1 25 | $1.3B | $1.7B | ||
| Q4 24 | $1.1B | $3.3B | ||
| Q3 24 | $1.3B | $3.3B | ||
| Q2 24 | $1.3B | $2.3B |
| Q1 26 | — | $2.6B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $8.2B | ||
| Q4 25 | $2.4B | $7.9B | ||
| Q3 25 | $2.3B | $7.3B | ||
| Q2 25 | $2.2B | $6.8B | ||
| Q1 25 | $2.3B | $6.3B | ||
| Q4 24 | $2.2B | $5.4B | ||
| Q3 24 | $2.4B | $6.1B | ||
| Q2 24 | $2.2B | $6.4B |
| Q1 26 | — | $40.0B | ||
| Q4 25 | $4.9B | $40.7B | ||
| Q3 25 | $4.8B | $39.9B | ||
| Q2 25 | $4.8B | $40.1B | ||
| Q1 25 | $4.8B | $38.4B | ||
| Q4 24 | $4.8B | $39.3B | ||
| Q3 24 | $5.2B | $41.8B | ||
| Q2 24 | $4.8B | $41.3B |
| Q1 26 | — | 0.32× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $283.3M | — |
| Free Cash FlowOCF − Capex | $270.3M | $188.0M |
| FCF MarginFCF / Revenue | 9.5% | 4.7% |
| Capex IntensityCapex / Revenue | 0.5% | — |
| Cash ConversionOCF / Net Profit | 1.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $953.4M | $1.6B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $283.3M | $1.2B | ||
| Q3 25 | $201.4M | $369.0M | ||
| Q2 25 | $179.2M | $227.0M | ||
| Q1 25 | $342.6M | $-105.0M | ||
| Q4 24 | $249.7M | $575.0M | ||
| Q3 24 | $90.0M | $693.0M | ||
| Q2 24 | $126.8M | $103.0M |
| Q1 26 | — | $188.0M | ||
| Q4 25 | $270.3M | $1.0B | ||
| Q3 25 | $190.3M | $233.0M | ||
| Q2 25 | $163.3M | $131.0M | ||
| Q1 25 | $329.5M | $-232.0M | ||
| Q4 24 | $239.7M | $446.0M | ||
| Q3 24 | $77.7M | $545.0M | ||
| Q2 24 | $118.8M | $6.0M |
| Q1 26 | — | 4.7% | ||
| Q4 25 | 9.5% | 21.6% | ||
| Q3 25 | 6.6% | 5.2% | ||
| Q2 25 | 6.2% | 3.1% | ||
| Q1 25 | 12.4% | -6.0% | ||
| Q4 24 | 8.1% | 10.5% | ||
| Q3 24 | 2.6% | 12.6% | ||
| Q2 24 | 4.9% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 3.0% | ||
| Q3 25 | 0.4% | 3.0% | ||
| Q2 25 | 0.6% | 2.3% | ||
| Q1 25 | 0.5% | 3.3% | ||
| Q4 24 | 0.3% | 3.1% | ||
| Q3 24 | 0.4% | 3.4% | ||
| Q2 24 | 0.3% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.41× | 2.41× | ||
| Q3 25 | 0.91× | 0.85× | ||
| Q2 25 | 0.98× | 0.80× | ||
| Q1 25 | 1.68× | -0.49× | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.72× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EXPD
| Customs Brokerage And Other Services | $1.1B | 40% |
| Airfreight Services | $1.1B | 39% |
| Ocean Freight And Ocean Services | $611.4M | 21% |
TEVA
Segment breakdown not available.
